Analgesics (Pharmacies) - Mozambique

  • Mozambique
  • Revenue in the Analgesics market is projected to reach US$2.84m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 13.16%, resulting in a market volume of US$5.27m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.08 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Mozambique is experiencing significant growth and development.

Customer preferences:
Customers in Mozambique have shown a growing preference for analgesics purchased from pharmacies. This can be attributed to several factors. Firstly, there is a growing awareness and concern about health and wellness among the population. As a result, consumers are increasingly seeking out over-the-counter pain relief options to address common ailments such as headaches, muscle aches, and fever. Secondly, pharmacies in Mozambique are seen as trusted sources of healthcare advice and products. Customers value the convenience and accessibility of purchasing analgesics from these establishments, as well as the assurance of quality and authenticity.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Mozambique is the increasing demand for non-steroidal anti-inflammatory drugs (NSAIDs). These medications are commonly used to relieve pain, reduce inflammation, and lower fever. The rising popularity of NSAIDs can be attributed to their effectiveness in addressing a wide range of pain-related conditions, as well as their availability over-the-counter in pharmacies. Additionally, there is a growing trend towards the use of combination analgesics, which contain a mixture of different active ingredients to provide targeted relief for specific types of pain.

Local special circumstances:
Mozambique has a unique set of circumstances that contribute to the development of the Analgesics (Pharmacies) market. Firstly, the country has a rapidly growing population, with a significant proportion of young people. This demographic trend is driving increased demand for analgesics, as younger individuals are more likely to engage in physical activities that may lead to pain or injury. Furthermore, Mozambique has a high prevalence of infectious diseases, such as malaria, which can cause fever and body aches. This creates a need for analgesics to alleviate symptoms and improve quality of life.

Underlying macroeconomic factors:
Several macroeconomic factors are influencing the development of the Analgesics (Pharmacies) market in Mozambique. Firstly, the country's economy has been growing steadily in recent years, resulting in increased disposable income among the population. This has led to greater affordability and willingness to spend on healthcare products, including analgesics. Additionally, Mozambique has seen improvements in healthcare infrastructure and access to healthcare services. This has led to an increase in the number of pharmacies and the availability of analgesics, further driving market growth. Finally, the government of Mozambique has implemented policies to promote the use of generic medications, which are often more affordable than branded alternatives. This has contributed to the affordability and accessibility of analgesics in the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)